
Коррекция сопутствующего дефицита магния у детей с неконтролируемой бронхиальной астмой позволяет повысить эффективность базисной терапии в отношении достижения контроля астмы и обладает фармакоэкономическими преимуществами, снижая затраты на достижение контроля и стоимость одного бессимптомного дня через 12 недель терапии.
Concomitant correction of magnesium deficiency in children with uncontrolled asthma can improve the efficiency of basic therapy in achieving asthma control; it shows pharmacoeconomic benefits in reducing the cost of achieving control and the cost per symptom-free day after 12 weeks of therapy
ДЕТИ,ДЕФИЦИТ МАГНИЯ,БРОНХИАЛЬНАЯ АСТМА,ФАРМАКОЭКОНОМИЧЕСКИЕ ИССЛЕДОВАНИЯ,АНАЛИЗ "ЗАТРАТЫ/ЭФФЕКТИВНОСТЬ",CHILDREN,MAGNESIUM DEFICIENCY,ASTHMA,PHARMACOECONOMIC STUDIES,COST / BENEFIT ANALYSIS
ДЕТИ,ДЕФИЦИТ МАГНИЯ,БРОНХИАЛЬНАЯ АСТМА,ФАРМАКОЭКОНОМИЧЕСКИЕ ИССЛЕДОВАНИЯ,АНАЛИЗ "ЗАТРАТЫ/ЭФФЕКТИВНОСТЬ",CHILDREN,MAGNESIUM DEFICIENCY,ASTHMA,PHARMACOECONOMIC STUDIES,COST / BENEFIT ANALYSIS
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
